Description

PRODUCT OVERVIEW

Two Peptides for Laboratory Research

This blend combines:

· CJC-1295 Without DAC (5mg): A modified GHRH analogue associated with research into GHRH-related signaling.

· Ipamorelin (IPA) (5mg): A synthetic pentapeptide studied for its interaction with the growth hormone secretagogue receptor, GHS-R1a.

The two components are structurally distinct and interact with different receptor systems. Their combination is of scientific interest when examining peptide characteristics and related signaling pathways. However, findings involving either component individually do not establish the effectiveness or properties of the combined formulation.

PRODUCT SPECIFICATIONS

SCIENTIFIC BACKGROUND

CJC-1295 Without DAC is commonly associated with modified GHRH analogue research, while Ipamorelin has been investigated as a selective agonist of the GHS-R1a receptor. These represent distinct molecular approaches to studying pathways associated with growth hormone release.

The available research on the individual compounds should not be interpreted as direct evidence for this specific 5mg + 5mg blend. In particular, research involving DAC-modified CJC-1295 does not automatically apply to the version without DAC.

RESEARCH APPLICATIONS

This peptide blend may be considered for controlled laboratory work involving:

· Peptide Characterization: Examination of the reported identity and analytical properties of each component.

· Receptor-Related Research: Investigation of the distinct receptor pathways associated with GHRH analogues and Ipamorelin.

· Composition Analysis: Review of the stated 5mg + 5mg formulation and total labeled quantity.

· Comparative Research: Evaluation of documented differences between individual peptide materials and combined formulations.

· Analytical Documentation: Review of batch identifiers, reported purity, and available laboratory findings.

These are research areas, not claims of demonstrated clinical outcomes or product-specific biological effects.

QUALITY & LABORATORY DOCUMENTATION

Products are supported by applicable third-party laboratory testing documentation. Independent verification and additional testing may be conducted where appropriate.

Researchers should review available documentation for compound identity, reported purity, analytical methods, laboratory information, and batch identification. For a multi-component blend, documentation should clearly identify both peptide components and correspond to the relevant product lot.

LOT & BATCH REFERENCE

Where a batch or lot identifier is provided, retain it with the corresponding product and laboratory records. This supports traceability and helps researchers compare the listed composition with the available analytical documentation.

STORAGE & HANDLING

Follow the supplier-provided storage specifications and applicable laboratory handling procedures. Refer to the product-specific documentation for appropriate storage conditions and packaging requirements.

RESEARCH USE STATEMENT

This product is offered strictly for laboratory and scientific research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.

IMPORTANT NOTICE

The stated composition describes the product listing and does not independently verify the identity, purity, or performance of the supplied material. Review the applicable specifications and batch documentation before laboratory evaluation. No claim is made that this product is approved for human use or has established clinical benefits.